ARTHEx Biotech
Developing microRNA modulators for diseases with unmet medical needs
Spain
28 employees
Series B
Total: $62.95M
Biotechnology
General Information
Spain
BounceWatch is an independent company data service, not affiliated with ARTHEx Biotech. To contact ARTHEx Biotech, visit arthexbiotech.com.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
How does ARTHEx Biotech compare?
A PDF of ARTHEx Biotech and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Meeting ARTHEx Biotech soon?
A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample
Discover More
Spain Market
Biotechnology
About ARTHEx Biotech
Business keywords: Biotech, Biomedical research, Oligonucleotide therapies, MicroRNA modulation, Genetic diseases, Drug development, Neuromuscular diseases, Orphan disease treatments, Antisense RNA, Medical innovation, University spin-off, Pharmacological research, Clinical advisory, Rare diseases
Funding Rounds & Investors (6)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Series B | €42.00M | 7 |
|
03 May 2023 |
| Venture Round | €11.50M | 1 |
|
25 Oct 2022 |
| Grant | €2.50M | 1 |
|
14 Oct 2022 |
| Seed Round | €4.25M | 2 |
Invivo Capital Partners, AdBio partners
|
24 Jul 2020 |
| Seed Round | €1.20M | 1 |
Centre for the Development of Industrial Technology (CDTI)
|
01 Jun 2020 |
| Seed Round | €1.50M | 1 |
Invivo Capital Partners
|
08 Jan 2020 |
ARTHEx Biotech Alternatives & Competitors
View All Alternatives
Dynacure develops new treatments for orphan disorders, focusing on CNM through Dyn101 program with I...
Unfolding the next generation of allosteric small molecule therapies to meet patient needs
Better Technology. Better Delivery. Developing a new generation of disease-modifying therapies.
FAQ About ARTHEx Biotech
Source: BounceWatch company record for ARTHEx Biotech, https://bouncewatch.com/company/arthex-biotech, updated 10 October 2024. When citing, please name BounceWatch and link this page.
